Quantedge Capital Pte LTD Alkermes Plc. Transaction History
Quantedge Capital Pte LTD
- $307 Million
- Q1 2025
A detailed history of Quantedge Capital Pte LTD transactions in Alkermes Plc. stock. As of the latest transaction made, Quantedge Capital Pte LTD holds 881,900 shares of ALKS stock, worth $27 Million. This represents 9.48% of its overall portfolio holdings.
Number of Shares
881,900
Previous 57,900
1423.14%
Holding current value
$27 Million
Previous $1.67 Million
1648.95%
% of portfolio
9.48%
Previous 0.64%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$891 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$557 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$361 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$246 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$211 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.03B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...